Bladder cancer
Select a topic to solve related cases or follow a course topic
-
Topic 1Follow-up surveillance regimes to consider for (very) high-risk NMIBC and MIBC
-
Topic 2UPDATED --- Targeted therapies for metastatic UCa in special populations
-
Topic 3UPDATED --- First-line therapy of synchronous and metachronous metastatic UCa
-
Topic 4UPDATED --- New hope for patients progressing after prior treatment for mUCa
-
Topic 5Handling AEs of targeted therapies for metastatic UCa
-
Topic 6Molecular diagnostics in the era of targeted therapies for mUCa
-
Topic 7Adjuvant treatment approaches for MIBC
-
Topic 8Histological subtypes of (N)MIBC: managed differently compared to pure UCa?
-
Topic 9Initial treatment of MIBC
-
Topic 10Follow-up surveillance regimes for low-/intermediate-risk NMIBC
-
Topic 11Low- and intermediate-risk NMIBC: surveillance or intravesical therapy?
-
Topic 12Challenges in high-risk NMIBC
Meet our multidisciplinary team of contributing experts
Editor in chief
Maria De Santis
Go to our other case-based CME offerings:
Do the 5-minute QuickScan to test if you're up to date and complete your personalised case journey. Available for various disease areas and specialties.
Take a minute to solve your weekly case challenge. Subscribe for free to receive them in your mailbox.